Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

1. Abrisqueta, P.
2. González-Barca, E.
3. Ferrà, C.
4. Ríos-Herranz, E.
5. Fernández de la Mata, M.
6. Delgado, J.
7. Andreu, R.
8. Hernández-Rivas, J.Á.
9. Terol, M.J.
10. Navarro, A.
11. Vidriales, M.B.
12. Baltasar, P.
13. De la Serna, J.
14. Ramírez, Á.
15. Ballester, C.
16. Moreno, C.
17. García-Marco, J.A.
18. Córdoba, R.
19. Yáñez, L.
20. Casado, L.F.
21. González, M.
22. Bosch, F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.ECLINM.2024.102642 GOOGLE SCHOLAR lock_openOpen access editor